November 11, 2008 - Global Therapeutics today initiated of the world's first clinical trial of a drug-eluting stent that uses an antisense RNA therapeutics agent aimed at silencing one of the genes (c-myc) responsible for causing arteries to reclose after stenting (restenosis).

The company said it hopes the ground-breaking technology advances the science of treating coronary artery disease beyond what current technologies can achieve. Trial results are expected in 2009.

Invivoā€™s next-generation MRI patient vital signs monitor, the Precess Patient Management Configuration, is built off of Invivoā€™s flagship Precess 3160 platform and reportedly utilizes the industryā€™s first wireless ECG and wireless SpO2 patient vital signs.

November 10, 2008 - GE Healthcare launched three new cardiac ultrasound devices for the U.S. market to aid 4D heart imaging and quantitative analysis at the 2008 meeting of the American Heart Association.

November 10, 2008 - Boston Scientific Corp. today said it received FDA approval to market its Apex PTCA Dilatation Catheter, a high-performance pre-dilatation balloon catheter developed specifically to address physicians' needs in treating the most challenging atherosclerotic lesions.

The catheter is available for distribution in both Monorail and Over-The-Wire (OTW) catheter platforms.

November 10, 2008 - INFINITT North America said this week it will introduce its Xelis Cardiac software tool, which uses 3D volume rendering and other post-processing techniques to improve visualization and analysis of coronary vessels, at this year's RSNA Nov. 30 - Dec. 5 in Chicago.

INFINITT North America's Xelis Cardiac software tool uses 3D volume rendering and other post-processing techniques to improve visualization and analysis of coronary vessels.

November 10, 2008 - GE Healthcare launched three new cardiac ultrasound devices for the U.S. market to aid 4D heart imaging and quantitative analysis at the 2009 meeting of the American Heart Association.

November 10, 2008 - The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) is a three-day program dedicated to cell-based therapies for cardiovascular repair and regeneration at the New York Academy of Medicine in New York City.

CoronaryScore is a software program for detecting and scoring calcifications in the coronary arteries developed by the medical imaging company Image Analysis Inc.

November 7, 2008 ā€“ The UK Department of Health announced today the launch of a database that will help identify the incidence and causes of sudden cardiac death and help save the lives of people who may currently be at risk from the inherited heart condition that can strike without warning.

Designed by pathologists and cardiologists, and funded by the Department of Health, the database will be a key tool in understanding the incidence and causes of inheritable conditions that can cause sudden cardiac death.

Subscribe to
Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now